Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking - Diagnosing Health Care Podcast

Epstein Becker & Green
Contact
This Diagnosing Health Care episode dives into the status of the Food and Drug Administration’s (“FDA’s”) plan for regulating cannabis and cannabis-derived products and what actions the agency has taken recently to make progress. The episode features Delia Deschaine and is hosted by Megan Robertson, both attorneys in the Washington, DC, office of Epstein Becker Green.

Here’s a preview of what you’ll hear:

“As we started to learn more about the plant’s therapeutic See more +

This Diagnosing Health Care episode dives into the status of the Food and Drug Administration’s (“FDA’s”) plan for regulating cannabis and cannabis-derived products and what actions the agency has taken recently to make progress. The episode features Delia Deschaine and is hosted by Megan Robertson, both attorneys in the Washington, DC, office of Epstein Becker Green.

Here’s a preview of what you’ll hear:

“As we started to learn more about the plant’s therapeutic potential, the interest in developing potential medical therapies that contain cannabinoids has exponentially grown.” – Delia Deschaine, Member of the Firm

“While there's been some positive movement, a lot of barriers still exist for researchers to kind of create that initial threshold comfortable level for FDA safety with respect to these products.” – Megan Robertson, Associate

The Diagnosing Health Care podcast examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.

Visit http://www.DiagnosingHealthCare.com See less -

Embed
Copy

Other MultiMedia by Epstein Becker & Green

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Epstein Becker & Green | Attorney Advertising

Written by:

Epstein Becker & Green
Contact
more
less

Epstein Becker & Green on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.